Stemedica Issued U.S. Patent For Stem Cell Treatment of Diabetic…

Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors announced that the Company has been issued U.S. Patent #8,318,485 by the United States…(PRWeb December 20, 2012)Read the full story at h…



Aspiring Photonics Entrepreneurs to Vie for Prizes, Connections in…

A total of $17,500 will be awarded to the top three competitors in the 2013 SPIE Startup Challenge, a live photonics business pitch competition. Preliminary judging has begun, and winners will be…(PRWeb December 19, 2012)Read the full story at htt…



The Conference Forum Announces A New Medicaid Rebate Summit for Early…

A new Medicaid Rebate Summit in 2013 will address the interpretation of the anticipated Final Rule, the larger implications of health care reform including financial and operational impact as well as…(PRWeb December 19, 2012)Read the full story at…



Rigaku Publishes New Method for Sulfur Analysis of Petroleum Products…

A new application note from Rigaku demonstrates that sulfur in petroleum products can be routinely analyzed in both low and high concentration ranges with accuracy and precision, meeting the…(PRWeb December 19, 2012)Read the full story at http://w…



UroToday Launches New Prostate Cancer Focused Content Including…

Digital Science Press, Inc. announces UroToday.com is expanding editorial content with more indepth clinical education for the urologists and medical oncologists on immunotherapy treatments for men…(PRWeb December 19, 2012)Read the full story at h…



Opedix® Kinetic Health Gear Unveils New KNEE-Tec™ Knee Support…

The latest line of Opedix joint and knee support compression apparel is designed to improve athletic performance by enhancing knee and hip joint function. Opedix tights are scientifically engineered…(PRWeb December 19, 2012)Read the full story at…



Dr. Bradley Vince of Vince & Associates in Kansas City Featured in…

Dr. Bradley Vince, Founder, Medical Director, and President of Vince & Associates Clinical Research (VACR), a leading provider of Phase I-III clinical trial research for the global pharmaceutical…(PRWeb December 19, 2012)Read the full story at…